However, amid all the buzz, there is also confusion
Counterfeit products have caused serious harm, including hospitalisations
No, GLP-1 receptor agonists are not licensed or approved for addiction treatment in the UK
El gasto calrico que implica caminar no es suficiente como para que el metabolismo tenga la necesidad de movilizar los lpidos almacenados
About tirzepatide Tirzepatide is a once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that integrates the actions of both incretins into a single novel molecule
Overview of the available GLP-1RAs listed according to their reported half-lives ( t 1/2 ) and the current clinical evidence of their effect in treatment of BAD Here, we review the scarce literature on the use of different GLP-1RAs in BAD treatment and discuss the potential of different GLP-1RAs in the context of their pharmacokinetic profiles, which we speculate may be important determinants of their mode of actions and, thus, pharmacodynamics in BAD